FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082161768> ?p ?o ?g. }

• W3082161768 endingPage "1041" @default.
• W3082161768 startingPage "1036" @default.
• W3082161768 abstract "Introduction Vancomycin pharmacokinetic data in critically ill patients receiving sustained low‐efficiency dialysis (SLED) is limited. Published data using vancomycin with intermittent hemodialysis and continuous renal replacement therapy may not be applicable to hybrid dialysis modalities such as SLED. Current drug references lack recommendations for vancomycin dosing in patients receiving SLED. Objective The objective of this study was to determine vancomycin pharmacokinetics during SLED. Methods A total of 20 patients who were critically ill with oliguric or anuric renal failure who received vancomycin and SLED were included in the study. Surrounding one SLED session, serum vancomycin blood samples were drawn before the initiation of SLED, at the termination of SLED, and 4 hours after completion of SLED treatment. Following this, patients received vancomycin, dosed to target a goal peak of 20–30 mcg/ml. A vancomycin peak level was drawn 1 hour after the end of the infusion. SLED treatment duration was at least 7 hours. Continuous data are reported as median (interquartile range) and categorical data as percentage. Results The vancomycin elimination rate and half‐life were 0.051 hours (0.042–0.074 hours) and 13.6 hours (9.4–16.6 hours), respectively. SLED reduced vancomycin serum concentrations by 35.4% (31.5–43.8%), and vancomycin rebound was 9.8% (2.5–13.7%). The vancomycin dose administered post‐SLED was 1000 mg (875–1125 mg). For 18 patients, the patient‐specific volume of distribution was 0.88 L/kg (0.67–1.1 L/kg), vancomycin clearance was 3.5 L/hr (2.2–5.2 L/hr), and the area under the concentration‐time curve during the study time period was 280.8 mg·hr/L (254.7–297.3 mg·hr/L). Conclusion Vancomycin is significantly removed during SLED with little rebound in serum concentrations 4 hours after completion of SLED. Based on study findings, patients who are critically ill require additional vancomycin dosing after each SLED session to maintain therapeutic post‐SLED vancomycin concentrations. Therapeutic drug monitoring of vancomycin is recommended during SLED." @default.
• W3082161768 created "2020-09-08" @default.
• W3082161768 creator A5014041164 @default.
• W3082161768 creator A5064498003 @default.
• W3082161768 creator A5069656248 @default.
• W3082161768 creator A5087505010 @default.
• W3082161768 date "2020-09-22" @default.
• W3082161768 modified "2023-10-09" @default.
• W3082161768 title "Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low‐Efficiency Dialysis" @default.
• W3082161768 cites W135731369 @default.
• W3082161768 cites W1557489755 @default.
• W3082161768 cites W1970899848 @default.
• W3082161768 cites W1977973815 @default.
• W3082161768 cites W1982109043 @default.
• W3082161768 cites W2004888852 @default.
• W3082161768 cites W2013678400 @default.
• W3082161768 cites W2016626098 @default.
• W3082161768 cites W2017487363 @default.
• W3082161768 cites W2053307458 @default.
• W3082161768 cites W2055045813 @default.
• W3082161768 cites W2060357576 @default.
• W3082161768 cites W2066608027 @default.
• W3082161768 cites W2074689673 @default.
• W3082161768 cites W2105151302 @default.
• W3082161768 cites W2132466276 @default.
• W3082161768 cites W2151155103 @default.
• W3082161768 cites W2167035694 @default.
• W3082161768 cites W2189335706 @default.
• W3082161768 cites W2327880406 @default.
• W3082161768 cites W2337907637 @default.
• W3082161768 cites W2576731998 @default.
• W3082161768 cites W2791625562 @default.
• W3082161768 cites W2883991663 @default.
• W3082161768 cites W2886269609 @default.
• W3082161768 cites W2964339291 @default.
• W3082161768 cites W2972004072 @default.
• W3082161768 cites W3010674765 @default.
• W3082161768 cites W3012260518 @default.
• W3082161768 doi "https://doi.org/10.1002/phar.2460" @default.
• W3082161768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32866291" @default.
• W3082161768 hasPublicationYear "2020" @default.
• W3082161768 type Work @default.
• W3082161768 sameAs 3082161768 @default.
• W3082161768 citedByCount "5" @default.
• W3082161768 countsByYear W30821617682021 @default.
• W3082161768 countsByYear W30821617682022 @default.
• W3082161768 crossrefType "journal-article" @default.
• W3082161768 hasAuthorship W3082161768A5014041164 @default.
• W3082161768 hasAuthorship W3082161768A5064498003 @default.
• W3082161768 hasAuthorship W3082161768A5069656248 @default.
• W3082161768 hasAuthorship W3082161768A5087505010 @default.
• W3082161768 hasConcept C112705442 @default.
• W3082161768 hasConcept C119060515 @default.
• W3082161768 hasConcept C126322002 @default.
• W3082161768 hasConcept C139254425 @default.
• W3082161768 hasConcept C141071460 @default.
• W3082161768 hasConcept C2777288759 @default.
• W3082161768 hasConcept C2778063415 @default.
• W3082161768 hasConcept C2778980435 @default.
• W3082161768 hasConcept C2779489039 @default.
• W3082161768 hasConcept C2779978075 @default.
• W3082161768 hasConcept C35294091 @default.
• W3082161768 hasConcept C42219234 @default.
• W3082161768 hasConcept C523546767 @default.
• W3082161768 hasConcept C54355233 @default.
• W3082161768 hasConcept C71924100 @default.
• W3082161768 hasConcept C86803240 @default.
• W3082161768 hasConceptScore W3082161768C112705442 @default.
• W3082161768 hasConceptScore W3082161768C119060515 @default.
• W3082161768 hasConceptScore W3082161768C126322002 @default.
• W3082161768 hasConceptScore W3082161768C139254425 @default.
• W3082161768 hasConceptScore W3082161768C141071460 @default.
• W3082161768 hasConceptScore W3082161768C2777288759 @default.
• W3082161768 hasConceptScore W3082161768C2778063415 @default.
• W3082161768 hasConceptScore W3082161768C2778980435 @default.
• W3082161768 hasConceptScore W3082161768C2779489039 @default.
• W3082161768 hasConceptScore W3082161768C2779978075 @default.
• W3082161768 hasConceptScore W3082161768C35294091 @default.
• W3082161768 hasConceptScore W3082161768C42219234 @default.
• W3082161768 hasConceptScore W3082161768C523546767 @default.
• W3082161768 hasConceptScore W3082161768C54355233 @default.
• W3082161768 hasConceptScore W3082161768C71924100 @default.
• W3082161768 hasConceptScore W3082161768C86803240 @default.
• W3082161768 hasIssue "10" @default.
• W3082161768 hasLocation W30821617681 @default.
• W3082161768 hasOpenAccess W3082161768 @default.
• W3082161768 hasPrimaryLocation W30821617681 @default.
• W3082161768 hasRelatedWork W113810927 @default.
• W3082161768 hasRelatedWork W1529790250 @default.
• W3082161768 hasRelatedWork W2034838466 @default.
• W3082161768 hasRelatedWork W2049905075 @default.
• W3082161768 hasRelatedWork W2055045813 @default.
• W3082161768 hasRelatedWork W2849524883 @default.
• W3082161768 hasRelatedWork W2965604448 @default.
• W3082161768 hasRelatedWork W3205393664 @default.
• W3082161768 hasRelatedWork W4319461748 @default.
• W3082161768 hasRelatedWork W4361277784 @default.
• W3082161768 hasVolume "40" @default.

• next